Economic Evaluation of Nivolumab Versus Docetaxel for the Treatment of Advanced Squamous and Non-squamous Non-small Cell Lung Cancer After Prior Chemotherapy in China

OBJECTIVE: To evaluate the economic value of nivolumab versus docetaxel for advanced non-small cell lung cancer (aNSCLC) treatment after platinum-based chemotherapy in adults without epidermal growth factor receptor/anaplastic lymphoma kinase aberrations in China. METHODS: Partitioned survival model...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Shanlian, Tang, Zhiliu, Harrison, James P., Hertel, Nadine, Penrod, John R., May, Jessica R., Juarez-Garcia, Ariadna, Holdgate, Orban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043099/
https://www.ncbi.nlm.nih.gov/pubmed/36897427
http://dx.doi.org/10.1007/s41669-022-00383-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043099/
https://www.ncbi.nlm.nih.gov/pubmed/36897427
http://dx.doi.org/10.1007/s41669-022-00383-x

Ejemplares similares